Preparation and use of a stable formulation of allosteric effector compounds

Details for Australian Patent Application No. 2003230766 (hide)

Owner ALLOS THERAPEUTICS, INC.

Inventors Johnson, Douglas Giles; Doty, Mark; Kipp, James E

Agent Davies Collison Cave

Pub. Number AU-A-2003230766

PCT Number PCT/US03/09818

PCT Pub. Number WO2003/086324

Priority 10/120,848 10.04.02 US

Filing date 2 April 2003

Wipo publication date 27 October 2003

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 10/120,848 10.04.02 US

4 December 2003 Application Open to Public Inspection

  Published as AU-A-2003230766

28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003230767-METHODS OF PROMOTING CELL VIABILITY

2003230765-Use of statins and other immunomodulatory agents in the treatment of autoimmune disease